These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 29421925)

  • 1. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM; Kanigsberg ND; Ramien ML
    J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.
    Coulombe J; Belzile E; Duhamel A; Rault P; Buteau C; DeBruycker JJ; Bussières JF
    J Cutan Med Surg; 2019; 23(5):547-550. PubMed ID: 31478770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.
    Chong I; Chao A
    Perm J; 2017; 21():16-060. PubMed ID: 28488978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid remission of Stevens-Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature.
    Wang R; Zhong S; Tu P; Li R; Wang M
    Dermatol Ther; 2019 Jul; 32(4):e12832. PubMed ID: 30659711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential.
    So N; Leavitt E; Aleshin M; Worswick S
    Dermatol Ther; 2018 Sep; 31(5):e12684. PubMed ID: 30175438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gilbert M; Scherrer LA
    Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of interstitial lung disease related to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review.
    Wang F; Gao X; Chen X; Tang X; Chen H; Han J
    J Dermatol; 2019 Nov; 46(11):1035-1038. PubMed ID: 31436331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y
    Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
    Meledathu S; Gordon M; Thornton M; Ashinoff R
    J Drugs Dermatol; 2023 Nov; 22(11):e24-e28. PubMed ID: 37943271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
    Schneider JA; Cohen PR
    Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
    Nwikue G; Olsson-Brown A; Aboheimed N; Yip V; Jolly C; Luchian A; Ressel L; Sharma A; Bergfeld W; Ahmed S; Dickinson A; Pirmohamed M; Carr DF
    J Dermatol; 2023 Sep; 50(9):1129-1139. PubMed ID: 37269158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children.
    St John J; Ratushny V; Liu KJ; Bach DQ; Badri O; Gracey LE; Ho AW; Raff AB; Sugai DY; Schalock P; Kroshinsky D
    Pediatr Dermatol; 2017 Sep; 34(5):540-546. PubMed ID: 28884910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Pham CH; Gillenwater TJ; Nagengast E; McCullough MC; Peng DH; Garner WL
    Burns; 2019 Nov; 45(7):1634-1638. PubMed ID: 31466921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Dreyer SD; Torres J; Stoddard M; Leavitt E; Sutton A; Aleshin M; Crew A; Worswick S
    Cutis; 2021 Jun; 107(6):E22-E28. PubMed ID: 34314327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R; Al Rumhi T; Al Abri AM
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease.
    Eliades P; Fonseca M; Harp J
    JAMA Dermatol; 2020 Aug; 156(8):921-922. PubMed ID: 32347889
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.